Align Technology Q4 Preview: Even After A Big Drop In Price, It's Too Expensive

Align Technology, Inc. is upgraded to Hold after a 30% decline versus SPY's 74% gain over three years. ALGN faces stagnant sales, margin compression, and lackluster growth, with 2025 showing revenue and margin declines. Management guides for sequential improvement in Clear Aligner volume and ASP, with Q4 consensus broadly in line with company expectations.

Seeking Alpha • a day ago

Align Technology Sponsors 30 Invisalign® Treatments Through Smiles4Canada Program to Provide Orthodontic Care to Children and Teens

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (NASDAQ: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced a new initiative with the Canadian Foundation for the Advancement of Orthodontics (CFAO). Under this initiative, Align has committed to support Invisalign treatment for 30 eligible pati.

Business Wire • Jan 13, 2026

Align Technology to Announce Fourth Quarter and 2025 Results on February 4, 2026

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report fourth quarter and full year 2025 financial results on Wednesday, February 4, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (2:0.

Business Wire • Jan 2, 2026

These stocks fell hard in 2025, but analysts see as much as 65% upside for them in 2026

Although the S&P 500 has returned 19.3% so far this year, dozens of stocks are showing significant declines for 2025.

Market Watch • Dec 29, 2025

Here's Why Align Technology (ALGN) is a Strong Momentum Stock

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • Dec 16, 2025

Align Technology: Attractive Entry After Q3 Beat And Multiple Compression

Align Technology (ALGN) is now rated Buy with a $180 target, offering ~10% upside after a significant correction and strong Q3 results. Q3 beat expectations: international demand and children's segment drove higher volumes, though average selling prices declined due to discounts and new markets. Adjusted operating margins improved to 23.9%, with aggressive buybacks and restructuring supporting EPS growth; GAAP margins impacted by one-time charges.

Seeking Alpha • Dec 12, 2025

Here's Why Align Technology (ALGN) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Zacks Investment Research • Dec 10, 2025

ALGN Stock Rises on Thailand Launch of Invisalign With MAOB

Align Technology's Thailand debut of Invisalign with MAOB lifts shares and expands its Class II treatment options for increasing patients.

Zacks Investment Research • Dec 9, 2025

Align Technology Announces Invisalign® System With Mandibular Advancement Featuring Occlusal Blocks for Class II Skeletal and Dental Correction

BANGKOK--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced commercial availability in Thailand of the Invisalign System with mandibular advancement featuring occlusal blocks designed specifically to address Class II skeletal and dental correction by.

Business Wire • Dec 9, 2025

Align Technology, Inc. (ALGN) Presents at Evercore 8th Annual Healthcare Conference Transcript

Align Technology, Inc. (ALGN) Presents at Evercore 8th Annual Healthcare Conference Transcript

Seeking Alpha • Dec 3, 2025